AMPLY Discovery is human health animal health AI machine learning small proteins peptides novelty antivirals antifungals anticancer bioprinting beating MDR Using evolutionary biology and AI to develop next generation pharmaceuticals Life is increasingly digitised. From individual organisms (genomes) to entire environments (metagenomes). This digital biome contains a near infinite supply of novel molecules for human and animal bioclinical use. Discover...
Location: United Kingdom
Employees: 1-10
Total raised: $4.54M
Founded date: 2021
Investors 2
| Date | Name | Website |
| 26.10.2023 | Techstars | techstars.... |
| 20.08.2022 | Clarendon ... | clarendon-... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 05.05.2025 | Seed | $1.75M | - |
| 12.02.2024 | - | $1.77M | - |
| 10.11.2022 | - | $1.03M | - |
Persons 4
| Date | First Name | Last Name | Title | Location | |||
| - | Jurnorain | Gani | Head of Re... | linkedin.c... | - | j*********... | - |
| - | Ben | Thomas | Chief Exec... | linkedin.c... | - | B********s... | - |
| - | Dermot | Tierney | Chief Comm... | linkedin.c... | - | d*********... | - |
| - | Mark | Beards | Chairman | linkedin.c... | - | m*********... | - |
Mentions in press and media 8
| Date | Title | Description |
| 13.02.2026 | AMPLY Discovery Receives Investment from Keeps Biomed | Dermot Tierney (AMPLY, COO), Ben Thomas (AMPLY, CEO), Oliver Rausch (AMPLY, CSO) AMPLY Discovery, a Belfast, Northern Ireland, UK-based developer of an AI-driven drug discovery platform, received a strategic investment from Keeps Biomed, a ... |
| 05.05.2025 | AMPLY Discovery Closes $1.75M Seed Funding | AMPLY Discovery, a Belfast, Northern Ireland, UK-based AI drug discovery startup, closed a $1.75M seed funding. The round was led by Twin Path Ventures, with participation from Venture Science, Co-fund NI, the British Business Bank, and QUB... |
| 02.05.2025 | The Intersection of AI and Healthcare: A New Era of Drug Discovery and Trade Challenges | In the realm of healthcare, two significant narratives are unfolding. On one side, a promising venture in drug discovery is harnessing the power of artificial intelligence (AI). On the other, the healthcare industry grapples with the reperc... |
| 01.05.2025 | Queen's University spin-out AMPLY Discovery secures $1.75M for AI drug discovery | AMPLY Discovery announced today that it has raised a $1.75 million seed round for its proprietary AI-driven drug discovery platform. Twin Path Ventures led the round, with participation from US-based Venture Science, Co-fund NI, the British... |
| 12.02.2024 | Belfast-based Amply secures £1.4M for AI-powered drug discovery platform | Amply, a Belfast-based biotech company, and not to be confused with Tech.eu jobs board partner Amply, has today confirmed the raise of over £1.4 million in grant funding. The startup intends to use the investment to further develop its AI-p... |
| 10.11.2022 | QUB spin-out Amply Discovery raises £900,000 to find new drug products! | - |
| - | AMPLY Discovery | “AMPLY Discovery is human health animal health AI machine learning small proteins peptides novelty antivirals antifungals anticancer bioprinting beating MDR Using evolutionary biology and AI to develop next generation pharmaceuticals Life i... |
| - | AMPLY Discovery | “Novel MedicinesDesigned by EvolutionDiscovered by AI Disease impacts us all…10 million people die will die this year from cancer and 50 million people are projected to die from drug resistant infections every year by 2050 … but making new ... |